#Dupuytren

Heads and Hands: Biomarkers
By: Charles Eaton
Jan 9, 2017

Heads and Hands: Biomarkers Biomarkers are the focus of Dupuytren Research Group research – the International Dupuytren Data Bank. Researchers in many medical specialties are searching for biomarkers, not just to find new treatments, but as a guide to current treatment. Blood test biomarkers are under investigation for better management and eventually prevention of  post-concussive […]

Read more ›
The Future is Coming!

Improving the Future of Dupuytren Care Right now, many people with mild Dupuytren biology do well after surgery or after Xiaflex – because most people have mild to moderate Dupuytren biology. The issue isn’t the patient with mild disease biology who will do well for a long time after any treatment. The issue is those […]

Read more ›
Happy Thanksgiving from the Dupuytren Foundation!

Turkey Day Update! Much has happened since the last Dupuytren Foundation report in July. The International Dupuytren Data Bank (IDDB) averages 100 new enrollees each month. We’re continuing to work out the complicated details of blood testing. If you haven’t enrolled yet, now is the time: http://DupStudy.com. Our international research committee continues to grow. So does […]

Read more ›
Dupuytren’s Disease Support Group Q&A
On: Sep 2, 2016
By: Charles Eaton

Dupuytren disease research questions and answers. Dupuytren advocacy is challenging. One challenge is that many people have never heard the words Dupuytren, or Ledderhose, or Peyronie, including many who have these problems. A larger challenge is that no one knows the root biology of Dupuytren/Ledderhose/Peyronie disease – how it starts, or how to make it […]

Read more ›
Dupuytren Foundation 2016 Mid-Year Report
On: Aug 30, 2016
By: Charles Eaton

Dupuytren Foundation 2016 Mid-Year Report 2016 has already exceeded expectations for the Dupuytren Foundation. Here are some of the highlights. Progress on International Dupuytren Data Bank Research The International Dupuytren Data Bank (IDDB) launched in November 2015. The goal of the IDDB is a cure for Dupuytren disease. This research has been made possible through your support. Project […]

Read more ›
Coffee for Dupuytren?
On: Aug 29, 2016
By: Charles Eaton

A recent study reported possible beneficial effects of caffeine on Dupuytren biology . There was 2011 study which reported similar results with forskolin, which affects the same cell chemistry as caffeine . Based on this, the possible use of caffeine was discussed in the Dupuytren Foundation blog in 2011 . Let’s look at two points in […]

Read more ›
PrimeDay Supports Dupuytren Foundation
On: Jul 12, 2016
By: Charles Eaton

Shop Amazon Prime Day July 12, and support The Dupuytren Foundation for free! The Dupuytren Foundation is a member of Amazon.com’s Amazon Smile program, which supports nonprofit charities on Amazon Prime Day (Today and every day). It’s a free and automatic way for you to support the Dupuytren Foundation every time you shop Amazon. The Dupuytren […]

Read more ›
Magnesium and Dupuytren disease
On: Jun 8, 2016
By: Charles Eaton

The cause of Dupuytren disease is a team effort of risks and stressors. Genes play the major role in one’s lifetime risk of disease. Not everyone with Dupuytren genes knows it: many people are genetic carriers. They carry the Dupuytren genes and pass them on to their children, yet never develop the disease themselves. Factors […]

Read more ›
Media coverage of Dupuytren Disease
On: Apr 18, 2016
By: Charles Eaton

There’s a been recent storm of Dupuytren related media coverage: A television news story interviewing Dupuytren Foundation executive director Dr. Charles Eaton and Dupuytren Foundation board member Tom Knapp: http://www.wpbf.com/news/whats-brewing-with-stephanie-berzinski-dupuytren-disease/39025076 Google books chose the chapter on Dupuytren disease authored by Dr. Charles Eaton to be the online example for the latest edition of the classic […]

Read more ›